Sexually Transmitted Infections · 2016 · 52 citations · 23 references
MedicineInfectious DiseasesOphthalmologyOcular DiseaseOcular PathologyVisual DisordersAntiretroviral TherapyInfectious Eye DiseaseVisual ImpairmentHuman Immunodeficiency Virus-associated Ocular DiseaseHuman Immunodeficiency Virus-associated UveitisInfectious Ocular DiseasePeripheral Visual AcuityPosterior Uveitis EvaluationStatic Visual AcuitySyphilitic UveitisVisual Function Loss
OBJECTIVE: To describe the clinical course and prognosis of ocular syphilis in patients infected with HIV-1 in the antiretroviral therapy (ART) era. METHODS: We conducted a single-centre retrospective chart review of ocular syphilis in patients infected with HIV-1 diagnosed between August 1997 and July 2015. The prognosis of best-corrected visual acuity (BCVA) was analysed. RESULTS: The study subjects were 30 eyes of 20 men who had sex with men (MSM) (median age, 41). Loss of vision and posterior uveitis were the most common ocular clinical features (43%) and location of inflammation at presentation (50%), respectively. The median baseline BCVA was 0.4 (IQR 0.2-1.2), including three eyes with hand motion. BCVA≤0.4 at diagnosis was significantly associated with posterior uveitis or panuveitis (p=0.044). Seventy-five per cent were treated with intravenous benzylpenicillin and 53% were diagnosed with neurosyphilis. After treatment (median follow-up: 21 months), BCVA improved in 89% of the eyes, including all eyes with hand motion, to a median BCVA of 1.2 (IQR 0.8-1.2). Kaplan-Meier analysis showed that >28 days of ocular symptoms before diagnosis was the only factor associated with poor prognosis of BCVA. Three patients (15%) developed recurrence after treatment. CONCLUSIONS: The prognosis of BCVA in HIV-infected patients with ocular syphilis in the ART era was favourable after proper treatment. Having >28 days of ocular symptoms before diagnosis was associated with poor prognosis. Changes in visual acuity in HIV-infected MSM should prompt an immediate assessment for ocular syphilis as delays in diagnosis and therapy can lead to irreversible visual loss.
23
Sexually transmitted diseases treatment guidelines (2015)
Kimberly Workowski, Gail Bolan · Reproductive Endocrinology · 2015 · 2.7K citations · Full text
2014 European guideline on the management of syphilis
M. Janier, V. Hegyi, N. Dupin et al. · Journal of the European Academy of Dermatology and Venereology · 2014 · 369 citations
Primary and Secondary Syphilis— United States, 1998
Monica E. Patton, John R. Su, Robert Nelson et al. · Archives of Dermatology · 2000 · 239 citations · Full text
Veterinary Medicine, Infectious Disease Control, Infectious Diseases +16